Ypsomed Holding AG Logo

Ypsomed Holding AG

Develops self-injection systems for pharma/biotech partners to simplify chronic disease therapy.

YPSN | SW

Overview

Corporate Details

ISIN(s):
CH0019396990
LEI:
391200QLIOTTBNPNSI14
Country:
Switzerland
Address:
Brunnmattstrasse 6, 3400 Burgdorf
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Ypsomed Holding AG is a leading developer and manufacturer of self-injection and infusion systems for self-medication. The company partners with pharmaceutical and biotech companies, providing a comprehensive portfolio of innovative platforms including injection pens, autoinjectors, and on-body devices. For over 40 years, Ypsomed has offered tailored self-care solutions designed to simplify therapy and improve quality of life for people with chronic conditions. Its platform ecosystem combines industrialized drug delivery technology with expert support services and integrated digital health solutions that support therapy management and clinical trials.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Ypsomed Holding AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Ypsomed Holding AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-09-30 N/A Executive member Buy None 145,600.00 CHF
2024-09-26 N/A Executive member Sell None 129,352.00 CHF
2024-09-24 N/A Non-Executive member Buy None 42,776.00 CHF
2024-05-27 N/A Executive member Sell None 78,000.00 CHF
2024-05-22 N/A Executive member Sell None 154,000.00 CHF
2023-09-29 N/A Executive member Sell None 40,800.00 CHF
2022-06-23 N/A Non-Executive member Buy None 31,400.00 CHF
2022-06-23 N/A Executive member Buy None 11,760.00 CHF
2022-06-23 N/A Executive member Buy None 122.50 CHF
2022-06-14 N/A Non-Executive member Buy None 1,080,875.72 CHF

Peer Companies

Company Country Ticker View
BrainCool AB Logo
Develops medical cooling systems to protect the brain after cardiac arrest, stroke, or injury.
Sweden BRAIN
Carl Zeiss Meditec AG Logo
Develops medical tech for ophthalmology & microsurgery, from diagnostics to surgical systems.
Germany AFX
CARMAT Logo
Develops an implantable artificial heart as a bridge-to-transplant for heart failure patients.
France ALCAR
CellaVision Logo
Provides digital microscopy solutions to automate blood analysis for global hematology labs.
Sweden CEVI
Develops bone grafts, artificial joints, and enzymes for the biopharmaceutical sector.
South Korea 049180
CG MedTech Co.,Ltd. Logo
Develops & sells orthopedic implants & devices using advanced biomaterial technology.
South Korea 056090
C.I.MEDICAL CO.,LTD. Logo
Mail-order supplier of 60k+ dental/medical items, also developing proprietary care products.
Japan 3540
Colan Totte.Co.,Ltd. Logo
Medical-grade magnetic wearables improving circulation & relieving stiffness for athletes & consumers.
Japan 7792
Coloplast Logo
Develops medical devices and services for people with intimate healthcare needs.
Denmark COLO
COLTENE Holding AG Logo
Develops and sells dental consumables and small equipment for dental professionals worldwide.
Switzerland CLTN

Talk to a Data Expert

Have a question? We'll get back to you promptly.